BioAffinity Technologies Inc
NASDAQ:BIAF
| Market Cap (Intraday) | 6.82M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.25 |
| 50-Day MA | $0.29 |
| 200-Day MA | $0.56 |
BioAffinity Technologies Inc Stock, NASDAQ:BIAF
3300 Nacogdoches Road, Suite 216, San Antonio, Texas 78217
United States of America
Phone: +1.210.698.5334
Number of Employees: 75
Description
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.